Abstract:Cancer therapy targets specific metabolic pathways or a single gene. This may result in low therapeutic effects due to drug selectivity and drug resistance. Recent studies revealed that the mitochondrial membrane potential and transmembrane permeability of cancerous mitochondria are differed from normal mitochondria. Thus, chemotherapy targeting cancerous mitochondria could be an innovative and competent strategy for cancer therapy. Previously, our work with a novel group of mitochondria targeting small molecules presented promising inhibitory capability toward various cancer cell lines and suppressed adenosine triphosphate (ATP) generation. Therefore, it is critical to understand the anticancer effect and targeting mechanism of these small molecules. This study investigated the inhibitory activity of mitochondria targeting small molecules with human cervical cancer cells - HeLa to further explore their therapeutic potential. HeLa cells were exposed to 10 mu M of syn-thesized compounds and presented elevation in intracellular reactive oxygen species (ROS) level, impaired mitochondrial membrane potential and upregulation of apoptosis as well as necrosis. In vivo, HeLa cell tumor-bearing BALB/c nude mice were treated with mitochondria targeting small molecules for 12 days consecu-tively. Throughout this chemotherapy study, no deleterious side effects nor the appearance of toxicity was observed. Furthermore, mitochondria targeting small molecules treated groups exhibited significant down-regulation with both tumor volume and tumor weight compared to the Doxorubicin (DOX) treated group. Thus, inhibition of mitochondrial ATP synthesis, activation of intracellular ROS production, down-regulation of mitochondrial membrane potential and upregulation of apoptosis and necrosis rates are the indications of cancer therapy. In this work, we examined the anticancer capability of four mitochondria targeting small molecules in vitro and in vivo, and demonstrated a novel therapeutic approach in cancer therapy with tremendous potential.

Cytotoxicity of mitochondrial-targeting silica-coated manganese oxide nanoparticles

Silver Nanoparticles Induce Apoptosis in HepG2 Cells through Particle-Specific Effects on Mitochondria

In Depth Analysis of Apoptosis Induced by Silica Coated Manganese Oxide Nanoparticles in Vitro.

A nanoselenium-coating biomimetic cytomembrane nanoplatform for mitochondrial targeted chemotherapy- and chemodynamic therapy through manganese and doxorubicin codelivery

Chemical transformation and cytotoxicity of iron oxide nanoparticles (IONPs) accumulated in mitochondria

Evaluating the safety and efficiency of nanomaterials: A focus on mitochondrial health

Anticancer Effect of Α-Tocopheryl Succinate Delivered by Mitochondria-Targeted Mesoporous Silica Nanoparticles.

In Vitro Cytotoxicity and Induction of Apoptosis by Silica Nanoparticles in Human HepG2 Hepatoma Cells

Hierarchical Nanoclusters with Programmed Disassembly for Mitochondria-Targeted Tumor Therapy with MR Imaging

Targeting Cancer Cells Through Mn(II)-dpa Grafted Silica Nanoparticles

Thermomagnetic Effect and Cytotoxicity of MnZn Ferrite Nanoparticles

Mechanism for α-MnO 2 nanowire-lnduced cytotoxicity in hela cells

Characterization and Cellular Toxicity Studies of Commercial Manganese Oxide Nanoparticles

Mitochondrial Electron Transport Chain Identified As a Novel Molecular Target of SPIO Nanoparticles Mediated Cancer-Specific Cytotoxicity.

Single-Atom Manganese Anchored on Carbon Dots for Promoting Mitochondrial Targeting and Photodynamic Effect in Cancer Treatment

A Mitochondria-Targeting Magnetothermogenic Nanozyme for Magnet-Induced Synergistic Cancer Therapy

ZnO nanomaterials target mitochondrial apoptosis and mitochondrial autophagy pathways in cancer cells

Mechanism for <I>α</I>-MnO<SUB>2</SUB> Nanowire-Induced Cytotoxicity in Hela Cells

Targeted Delivery of Doxorubicin to Mitochondria Using Mesoporous Silica Nanoparticle Nanocarriers.

Biological Evaluation of Mitochondria Targeting Small Molecules As Potent Anticancer Drugs.

Mechanism for alpha-MnO2 nanowire-induced cytotoxicity in Hela cells.